Reuters logo
BRIEF-Aspen Pharmacare says HY normalised HEPS rose 6 pct to 692 cents
March 9, 2017 / 5:34 AM / 9 months ago

BRIEF-Aspen Pharmacare says HY normalised HEPS rose 6 pct to 692 cents

March 9 (Reuters) - Aspen Pharmacare Holdings Ltd

* HY revenue for group grew 13% to R19,8 billion and normalised headline earnings per share increased by 6% to 692 cents

* Results in second half of 2017 financial year will be influenced by strengthening of rand

* Says overall stronger underlying performance in second half of 2017 financial year is anticipated Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below